Amrita Krishnan, MD, and Saad Z. Usmani, MD, MBA, FACP, offer their perspectives on the role of stem cell transplant and MRD testing in patients with newly diagnosed multiple myeloma.
Nemaura Medical Inc. (NASDAQ:NMRD – Get Free Report) COO Arash Ghadar-Ghadr acquired 100,000 shares of Nemaura Medical stock in a transaction that occurred on Friday, January 5th. The shares were purchased at an average cost of $0.14 per share, with a total value of $14,000.00. Following the transaction, the chief operating officer now owns 100,000 […]
Catherine E. Lai, MD, MPH, discusses the current standard of care in the first-line treatment of patients with AML and which factors guide therapy selection.